We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Two Industry Partnerships Initiated to Fuel Neuroscience Research

By LabMedica International staff writers
Posted on 16 Nov 2014
Print article
Faster, more complex neural research is now attainable by combining technology from two research companies.

Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd. (Nazareth, Israel) that will create a truly comprehensive set of tools for neuroscience researchers that should facilitate faster and more cost-effective research. Blackrock Microsystems will integrate specific technologies from PhenoSys and NAN Instruments to offer a fully cohesive range of electrophysiology research products.

“Our partnerships with PhenoSys and NAN instruments will fundamentally change the way neuroscientists work, so that regardless of the experiment the researcher dreams up, we can now empower them to perform it,” said Andy Gotshalk, CEO of Blackrock Microsystems. “Neuroscience research is often encumbered by mix-and-match components and complicated experiment setups. These partnerships will lessen time-consuming, expensive barriers and expedite research results so that we can achieve our ultimate objective of transferring those results into clinical practice for the millions of people facing devastating neurophysiologic challenges.”

Blackrock Microsystems’ miniaturized electrodes and amplifiers, and its data acquisition platform help researchers to perform experiments on nearly unencumbered subjects, thus yielding a clearer look into the brain's natural architecture.

PhenoSys’ technology allows researchers to construct virtual-reality mazes, where scientists can implement improvised alterations to experiments, leading to considerable cost savings of both time and money. Prior to this technology, researchers spent hours constructing physical mazes and other research environments.

“Our virtual-reality technology is already transforming neuroscience research,” said York Winter, PhD, CEO and co-founder of PhenoSys, and professor of cognitive neurobiology at Humboldt University (Berlin, Germany). “By teaming up with Blackrock Microsystems, we'll be able to help even more scientists conduct experiments that were previously thought impossible.”

NAN Instruments designs and manufactures the only electrode positioning system capable of moving individual electrodes fractions of a millimeter in a three-dimensional (3D) space. With this technology, neuroscientists can differentiate between neuron groups that were previously inseparable.

“NAN Instruments prides itself on providing flexible and reliable electrode drives,” said Nabeel Abunassar, CEO of NAN Instruments, Ltd. “Our collaboration with Blackrock Microsystems, leverages our combined strengths as leaders in the field of neuroscience research to provide integrated systems for our customers on a global scale.”

Blackrock Microsystems has become a world-leading provider of technology in the neuroscience, neural engineering, and neural prosthetics space. The company’s technology has been at the center of worldwide developments in brain machine interface), implantable bionic technologies and epilepsy diagnostics.

PhenoSys is a research and development company that engineers and markets advanced technology for automated animal behavior research. The PhenoSys investigators holds extensive expertise in electrical and mechanical engineering, computer science, and behavioral biology to create experimental systems used for behavioral phenotyping, brain research, experimental psychology, and diagnostic characterization of animal models for translational medicine.

NAN Instruments designs and manufactures devices for recording electrical activity from the brain and nervous system. The unique design of the company’s electrode positioning systems provides users with effective tools that allow manipulation of each electrode individually in 3D spaces.

Related Links:

Blackrock Microsystems 
PhenoSys 
NAN Instruments


Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Chemistry Analyzer
MS100
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.